Mammary gland development and function in maternal obesity and gestational diabetes

The mammary gland undergoes dynamic structural and functional remodeling during pregnancy to prepare for lactogenesis, driven by cellular signaling, immune interactions, and microenvironmental cues, including those from adipocytes. In maternal obesity, clinical data indicate that these patients often experience poor breastfeeding outcomes. The causes are multifactorial, but one contributing factor is impaired mammary gland development and function. The mechanisms underlying poor lactation outcomes resulting from obesity-induced mammary gland dysfunction remain poorly understood. To date, there are no FDA-approved galactagogues, which are milk production-promoting medications, highlighting a lack of treatments and understanding of functional lactation biology. In this review, we examine current literature on mammary gland development and dysfunction with a particular focus on the effects of maternal obesity during pregnancy and lactation.

Authors

Institutions

Publication Details

Journal
Current Opinion in Physiology
Published
2026-05-01
DOI
https://doi.org/10.1016/j.cophys.2026.100957
Primary Topic
Cancer Risks and Factors
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mammary gland development and function in maternal obesity and gestational diabetes

Kathryn L. Schwertfeger, Emilyn U. Alejandro, Brian Akhaphong
Current Opinion in Physiology
Cancer Risks and Factors
article

Mammary gland development and function in maternal obesity and gestational diabetes

Kathryn L. Schwertfeger, Emilyn U. Alejandro, Brian Akhaphong
article en

Abstract

The mammary gland undergoes dynamic structural and functional remodeling during pregnancy to prepare for lactogenesis, driven by cellular signaling, immune interactions, and microenvironmental cues, including those from adipocytes. In maternal obesity, clinical data indicate that these patients often experience poor breastfeeding outcomes. The causes are multifactorial, but one contributing factor is impaired mammary gland development and function. The mechanisms underlying poor lactation outcomes resulting from obesity-induced mammary gland dysfunction remain poorly understood. To date, there are no FDA-approved galactagogues, which are milk production-promoting medications, highlighting a lack of treatments and understanding of functional lactation biology. In this review, we examine current literature on mammary gland development and dysfunction with a particular focus on the effects of maternal obesity during pregnancy and lactation.

Current Opinion in Physiology
University of Minnesota (US)
National Institutes of Health
Good health and well-being
Openalex Percentile: Top 7%
Cancer Risks and Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.